Anthony H Barnett

Anthony H Barnett

UNVERIFIED PROFILE

Are you Anthony H Barnett?   Register this Author

Register author
Anthony H Barnett

Anthony H Barnett

Publications by authors named "Anthony H Barnett"

Are you Anthony H Barnett?   Register this Author

100Publications

1380Reads

6Profile Views

IDegLira: combining efficacy, durability, and convenience?

Lancet Diabetes Endocrinol 2019 Aug 9;7(8):584-585. Epub 2019 Jun 9.

Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30198-6DOI Listing
August 2019

Once-weekly GLP-1R agonists: moving the goal posts.

Lancet Diabetes Endocrinol 2018 04 1;6(4):260-261. Epub 2018 Feb 1.

Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK; Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587183004
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(18)30049-4DOI Listing
April 2018

Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences.

J Diabetes Res 2017 20;2017:1273789. Epub 2017 Mar 20.

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/1273789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376938PMC
January 2018

Type 2 diabetes in adolescents and young adults.

Lancet Diabetes Endocrinol 2018 01 25;6(1):69-80. Epub 2017 Aug 25.

Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587173018
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(17)30186-9DOI Listing
January 2018

Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy.

Diabetes Obes Metab 2017 10 9;19(10):1339-1352. Epub 2017 Jun 9.

Diabetes and Endocrine Centre, Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637910PMC
October 2017

Guidelines for type 2 diabetes: keeping a finger on the pulse.

Lancet Diabetes Endocrinol 2017 06 19;5(6):420. Epub 2017 Apr 19.

Institute of Life Science 2, Swansea University Medical School, Swansea, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30136-5DOI Listing
June 2017

Prevalence and Associations of Obstructive Sleep Apnea in South Asians and White Europeans with Type 2 Diabetes: A Cross-Sectional Study.

J Clin Sleep Med 2017 Apr 15;13(4):583-589. Epub 2017 Apr 15.

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://jcsm.aasm.org/ViewAbstract.aspx?pid=30993
Publisher Site
http://dx.doi.org/10.5664/jcsm.6548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359335PMC
April 2017

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Nat Rev Endocrinol 2016 Oct 24;12(10):566-92. Epub 2016 Jun 24.

School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2016.86DOI Listing
October 2016

Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database.

Curr Med Res Opin 2016 09 23;32(9):1465-75. Epub 2016 Mar 23.

c Diabetes and Endocrine Centre , Heart of England NHS Foundation Trust and University of Birmingham , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2016.1157462DOI Listing
September 2016

Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.

Curr Med Res Opin 2015 11;31(10):1919-31. Epub 2015 Sep 11.

d d Bharti Hospital and Bharti Research Institute of Diabetes and Endocrinology , Kamal , India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2015.1081589DOI Listing
May 2016

Future glucose-lowering drugs for type 2 diabetes.

Lancet Diabetes Endocrinol 2016 Apr 23;4(4):350-9. Epub 2016 Jan 23.

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/landia/PIIS2213-8587(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S221385871500462
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(15)00462-3DOI Listing
April 2016

The revised NICE draft guideline for type 2 diabetes: still a long way to go.

Lancet Diabetes Endocrinol 2015 Sep 4;3(9):679-80. Epub 2015 Aug 4.

University of Birmingham and Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(15)00288-0DOI Listing
September 2015

NICE draft type 2 diabetes guidelines: a cause for concern.

Lancet Diabetes Endocrinol 2015 Jun 13;3(6):403-405. Epub 2015 Mar 13.

University of Birmingham and Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587150005
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(15)00053-4DOI Listing
June 2015

In defence of NICE draft type 2 diabetes guidelines--Author's reply.

Lancet Diabetes Endocrinol 2015 Jun;3(6):406-407

University of Birmingham and Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(15)00132-1DOI Listing
June 2015

Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation.

Expert Opin Drug Saf 2015 Jan 29;14(1):149-59. Epub 2014 Oct 29.

Heart of England NHS Foundation Trust and University of Birmingham, Diabetes Centre , Birmingham , UK

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2014.97
Publisher Site
http://dx.doi.org/10.1517/14740338.2014.971008DOI Listing
January 2015

Empagliflozin for the treatment of type 2 diabetes.

Expert Opin Pharmacother 2014 Nov;15(16):2429-41

Heart of England NHS Foundation Trust, Department of Diabetes and Endocrinology , Birmingham , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.966078DOI Listing
November 2014

Elevated serum free light chains predict cardiovascular events in type 2 diabetes.

Diabetes Care 2014 Jul 17;37(7):2028-30. Epub 2014 Apr 17.

Diabetes Centre, Heart of England NHS Foundation Trust, Birmingham, U.K.University of Birmingham, Birmingham, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc13-2227DOI Listing
July 2014

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

Authors:
Anubha Mahajan Min Jin Go Weihua Zhang Jennifer E Below Kyle J Gaulton Teresa Ferreira Momoko Horikoshi Andrew D Johnson Maggie C Y Ng Inga Prokopenko Danish Saleheen Xu Wang Eleftheria Zeggini Goncalo R Abecasis Linda S Adair Peter Almgren Mustafa Atalay Tin Aung Damiano Baldassarre Beverley Balkau Yuqian Bao Anthony H Barnett Ines Barroso Abdul Basit Latonya F Been John Beilby Graeme I Bell Rafn Benediktsson Richard N Bergman Bernhard O Boehm Eric Boerwinkle Lori L Bonnycastle Noël Burtt Qiuyin Cai Harry Campbell Jason Carey Stephane Cauchi Mark Caulfield Juliana C N Chan Li-Ching Chang Tien-Jyun Chang Yi-Cheng Chang Guillaume Charpentier Chien-Hsiun Chen Han Chen Yuan-Tsong Chen Kee-Seng Chia Manickam Chidambaram Peter S Chines Nam H Cho Young Min Cho Lee-Ming Chuang Francis S Collins Marylin C Cornelis David J Couper Andrew T Crenshaw Rob M van Dam John Danesh Debashish Das Ulf de Faire George Dedoussis Panos Deloukas Antigone S Dimas Christian Dina Alex S Doney Peter J Donnelly Mozhgan Dorkhan Cornelia van Duijn Josée Dupuis Sarah Edkins Paul Elliott Valur Emilsson Raimund Erbel Johan G Eriksson Jorge Escobedo Tonu Esko Elodie Eury Jose C Florez Pierre Fontanillas Nita G Forouhi Tom Forsen Caroline Fox Ross M Fraser Timothy M Frayling Philippe Froguel Philippe Frossard Yutang Gao Karl Gertow Christian Gieger Bruna Gigante Harald Grallert George B Grant Leif C Grrop Chrisropher J Groves Elin Grundberg Candace Guiducci Anders Hamsten Bok-Ghee Han Kazuo Hara Neelam Hassanali Andrew T Hattersley Caroline Hayward Asa K Hedman Christian Herder Albert Hofman Oddgeir L Holmen Kees Hovingh Astradur B Hreidarsson Cheng Hu Frank B Hu Jennie Hui Steve E Humphries Sarah E Hunt David J Hunter Kristian Hveem Zafar I Hydrie Hiroshi Ikegami Thomas Illig Erik Ingelsson Muhammed Islam Bo Isomaa Anne U Jackson Tazeen Jafar Alan James Weiping Jia Karl-Heinz Jöckel Anna Jonsson Jeremy B M Jowett Takashi Kadowaki Hyun Min Kang Stavroula Kanoni Wen Hong L Kao Sekar Kathiresan Norihiro Kato Prasad Katulanda Kirkka M Keinanen-Kiukaanniemi Ann M Kelly Hassan Khan Kay-Tee Khaw Chiea-Chuen Khor Hyung-Lae Kim Sangsoo Kim Young Jin Kim Leena Kinnunen Norman Klopp Augustine Kong Eeva Korpi-Hyövälti Sudhir Kowlessur Peter Kraft Jasmina Kravic Malene M Kristensen S Krithika Ashish Kumar Jesus Kumate Johanna Kuusisto Soo Heon Kwak Markku Laakso Vasiliki Lagou Timo A Lakka Claudia Langenberg Cordelia Langford Robert Lawrence Karin Leander Jen-Mai Lee Nanette R Lee Man Li Xinzhong Li Yun Li Junbin Liang Samuel Liju Wei-Yen Lim Lars Lind Cecilia M Lindgren Eero Lindholm Ching-Ti Liu Jian Jun Liu Stéphane Lobbens Jirong Long Ruth J F Loos Wei Lu Jian'an Luan Valeriya Lyssenko Ronald C W Ma Shiro Maeda Reedik Mägi Satu Männisto David R Matthews James B Meigs Olle Melander Andres Metspalu Julia Meyer Ghazala Mirza Evelin Mihailov Susanne Moebus Viswanathan Mohan Karen L Mohlke Andrew D Morris Thomas W Mühleisen Martina Müller-Nurasyid Bill Musk Jiro Nakamura Eitaro Nakashima Pau Navarro Peng-Keat Ng Alexandra C Nica Peter M Nilsson Inger Njølstad Markus M Nöthen Keizo Ohnaka Twee Hee Ong Katharine R Owen Colin N A Palmer James S Pankow Kyong Soo Park Melissa Parkin Sonali Pechlivanis Nancy L Pedersen Leena Peltonen John R B Perry Annette Peters Janini M Pinidiyapathirage Carl G Platou Simon Potter Jackie F Price Lu Qi Venkatesan Radha Loukianos Rallidis Asif Rasheed Wolfgang Rathman Rainer Rauramaa Soumya Raychaudhuri N William Rayner Simon D Rees Emil Rehnberg Samuli Ripatti Neil Robertson Michael Roden Elizabeth J Rossin Igor Rudan Denis Rybin Timo E Saaristo Veikko Salomaa Juha Saltevo Maria Samuel Dharambir K Sanghera Jouko Saramies James Scott Laura J Scott Robert A Scott Ayellet V Segrè Joban Sehmi Bengt Sennblad Nabi Shah Sonia Shah A Samad Shera Xiao Ou Shu Alan R Shuldiner Gunnar Sigurđsson Eric Sijbrands Angela Silveira Xueling Sim Suthesh Sivapalaratnam Kerrin S Small Wing Yee So Alena Stančáková Kari Stefansson Gerald Steinbach Valgerdur Steinthorsdottir Kathleen Stirrups Rona J Strawbridge Heather M Stringham Qi Sun Chen Suo Ann-Christine Syvänen Ryoichi Takayanagi Fumihiko Takeuchi Wan Ting Tay Tanya M Teslovich Barbara Thorand Gudmar Thorleifsson Unnur Thorsteinsdottir Emmi Tikkanen Joseph Trakalo Elena Tremoli Mieke D Trip Fuu Jen Tsai Tiinamaija Tuomi Jaakko Tuomilehto Andre G Uitterlinden Adan Valladares-Salgado Sailaja Vedantam Fabrizio Veglia Benjamin F Voight Congrong Wang Nicholas J Wareham Roman Wennauer Ananda R Wickremasinghe Tom Wilsgaard James F Wilson Steven Wiltshire Wendy Winckler Tien Yin Wong Andrew R Wood Jer-Yuarn Wu Ying Wu Ken Yamamoto Toshimasa Yamauchi Mingyu Yang Loic Yengo Mitsuhiro Yokota Robin Young Delilah Zabaneh Fan Zhang Rong Zhang Wei Zheng Paul Z Zimmet David Altshuler Donald W Bowden Yoon Shin Cho Nancy J Cox Miguel Cruz Craig L Hanis Jaspal Kooner Jong-Young Lee Mark Seielstad Yik Ying Teo Michael Boehnke Esteban J Parra Jonh C Chambers E Shyong Tai Mark I McCarthy Andrew P Morris

Nat Genet 2014 Mar 9;46(3):234-44. Epub 2014 Feb 9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969612PMC
March 2014

Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.

Diab Vasc Dis Res 2014 Jan 29;11(1):34-40. Epub 2013 Oct 29.

Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164113507068DOI Listing
January 2014

Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.

BMC Res Notes 2014 Jan 17;7:42. Epub 2014 Jan 17.

Department of Biomolecular and Sport Sciences, Faculty of Health and Life Sciences, Coventry University, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-7-42DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929558PMC
January 2014

Linagliptin for elderly patients with type 2 diabetes - Authors' reply.

Lancet 2014 Jan;383(9914):307-8

Boehringer Ingelheim, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)60104-5DOI Listing
January 2014

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial.

Lancet 2013 Oct 13;382(9902):1413-23. Epub 2013 Aug 13.

Diabetes Centre, Heart of England NHS Foundation Trust, Birmingham, UK; University of Birmingham, Birmingham, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61500-7DOI Listing
October 2013

Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.

Clin Drug Investig 2013 Oct;33(10):707-17

Diabetes Centre, Heart of England National Health Service Foundation Trust and University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-013-0107-8DOI Listing
October 2013

SGLT inhibitors in management of diabetes.

Lancet Diabetes Endocrinol 2013 Oct 13;1(2):140-51. Epub 2013 Aug 13.

School of Life and Health Sciences, Aston University, Birmingham, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(13)70050-0DOI Listing
October 2013

Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus.

Postgrad Med 2013 Sep;125(5):92-100

Heart of England NHS Foundation Trust and University of Birmingham, UK. nhs.uk.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2013.09.2698DOI Listing
September 2013

High frequency of autoantibodies in patients with long duration type 1 diabetes.

Diabetologia 2013 Aug 20. Epub 2013 Aug 20.

Diabetes Research Group, Division of Diabetes and Nutritional Sciences, King's College London, Hodgkin Building, Guy's Campus, SE1 1UL, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-013-3017-7DOI Listing
August 2013

Cardiovascular benefits of incretins.

BMJ 2013 Jul 10;347:f4382. Epub 2013 Jul 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.f4382DOI Listing
July 2013

Complementing insulin therapy to achieve glycemic control.

Adv Ther 2013 Jun;30(6):557-76

Diabetes Centre, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-013-0039-y
Publisher Site
http://dx.doi.org/10.1007/s12325-013-0039-yDOI Listing
June 2013

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes.

J Clin Endocrinol Metab 2012 Dec 17;97(12):4605-12. Epub 2012 Oct 17.

Department of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff CF14 4UJ, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-3034DOI Listing
December 2012

Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses.

Curr Med Res Opin 2012 Dec 14;28(12):1933-46. Epub 2012 Nov 14.

The Brod Group, Mill Valley, CA 94941, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2012.743458DOI Listing
December 2012

Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.

Curr Med Res Opin 2012 Dec 14;28(12):1947-58. Epub 2012 Nov 14.

The Brod Group, Mill Valley, CA 94941, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2012.743457DOI Listing
December 2012

Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes.

Am J Respir Crit Care Med 2012 Sep 21;186(5):434-41. Epub 2012 Jun 21.

Centre of Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201112-2135OCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443800PMC
September 2012

Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus.

Exp Diabetes Res 2012 1;2012:895185. Epub 2012 Mar 1.

Clinical Sciences Research Laboratories, Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, University Hospital Coventry and Warwickshire, Coventry CV2 2DX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/895185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303685PMC
July 2012

SGLT-2 inhibitors in development for type 2 diabetes treatment.

Rev Diabet Stud 2011 10;8(3):348-54. Epub 2011 Nov 10.

Heart of England NHS Foundation Trust, Good Hope Hospital, Sutton Coldfield, Birmingham, B75 7RR, UK.

View Article

Download full-text PDF

Source
http://www.soc-bdr.org/content/e4/e887/volRdsVolumes10058/is
Publisher Site
http://dx.doi.org/10.1900/RDS.2011.8.348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280669PMC
June 2012

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin.

Curr Med Res Opin 2012 Apr 1;28(4):513-23. Epub 2012 Mar 1.

University of Birmingham and BioMedical Research Centre, Heart of England National Health Service Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2012.665046DOI Listing
April 2012

Insulin degludec: a new ultra-longacting insulin.

Lancet 2012 Apr;379(9825):1465-7

Centre of Endocrinology, Diabetes and Metabolism, Institute of Biomedical Research, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361260527
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(12)60527-3DOI Listing
April 2012

Renal protection with angiotensin receptor blockers: where do we stand.

J Nephrol 2011 Sep-Oct;24(5):569-80

Department of Nephrology and Hypertension, University Hospital Erlangen-Nuremberg, Krankenhausstrasse 12, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/JN.2011.6445DOI Listing
January 2012

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes.

Core Evid 2011 8;6:67-79. Epub 2011 Sep 8.

University of Birmingham and BioMedical Research Centre, Heart of England National Health Service Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CE.S15525DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195668PMC
November 2011

Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS.

Curr Med Res Opin 2011 Nov;27 Suppl 3:47-55

Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2011.614937DOI Listing
November 2011

Management of type 2 diabetes: new and future developments in treatment.

Lancet 2011 Jul 24;378(9786):182-97. Epub 2011 Jun 24.

Centre of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)60207-9DOI Listing
July 2011

Linagliptin: a novel dipeptidyl peptidase 4 inhibitor with a unique place in therapy.

Adv Ther 2011 Jun 17;28(6):447-59. Epub 2011 May 17.

Heart of England National Health Service Foundation Trust (Teaching), University of Birmingham and Biomedical Research Unit, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-011-0028-y
Publisher Site
http://dx.doi.org/10.1007/s12325-011-0028-yDOI Listing
June 2011

New treatments for type 2 diabetes in the UK - an evolving landscape.

Prim Care Diabetes 2011 Apr;5(1):1-7

Diabetes Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcd.2010.09.001DOI Listing
April 2011

Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.

Neurosci Lett 2011 Jan 12;487(2):144-8. Epub 2010 Oct 12.

Department of Biomolecular and Sport Sciences, Coventry University, West Midlands CV1 5FB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2010.10.010DOI Listing
January 2011

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.

Diabetes Ther 2010 Dec 19;1(2):45-56. Epub 2011 Jan 19.

Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, UK,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13300-010-0007-3
Publisher Site
http://dx.doi.org/10.1007/s13300-010-0007-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138480PMC
December 2010

Emerging treatment options for type 2 diabetes.

Br J Clin Pharmacol 2010 Nov;70(5):631-44

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK. Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2125.2010.03711.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2125.2010.03711.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997303PMC
November 2010

A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes.

Curr Diabetes Rev 2010 Nov;6(6):378-87

Public Health, Epidemiology, and Biostatistics, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
November 2010

Exenatide once weekly: clinical outcomes and patient satisfaction.

Patient Prefer Adherence 2010 Sep 7;4:313-24. Epub 2010 Sep 7.

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943223PMC
September 2010

Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy.

Curr Med Res Opin 2010 Jun;26(6):1333-42

University of Birmingham and Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1185/0300799100373806
Publisher Site
http://dx.doi.org/10.1185/03007991003738063DOI Listing
June 2010

Inhaled insulin: new formulation, new trial.

Lancet 2010 Jun;375(9733):2199-201

Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)60885-9DOI Listing
June 2010

Glycaemic control in type 2 diabetes: targets and new therapies.

Pharmacol Ther 2010 Feb 18;125(2):328-61. Epub 2009 Nov 18.

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016372580900211
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2009.11.001DOI Listing
February 2010

DPP-4 inhibitors in clinical practice.

Postgrad Med 2009 Nov;121(6):70-100

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3810/pgm.2009.11.2079
Publisher Site
http://dx.doi.org/10.3810/pgm.2009.11.2079DOI Listing
November 2009

UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).

Eur Arch Psychiatry Clin Neurosci 2009 Jun 9;259(4):239-47. Epub 2009 Mar 9.

Undergraduate Centre, Heart of England NHS Foundation Trust, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00406-008-0863-2
Publisher Site
http://dx.doi.org/10.1007/s00406-008-0863-2DOI Listing
June 2009

Redefining the role of thiazolidinediones in the management of type 2 diabetes.

Vasc Health Risk Manag 2009 8;5(1):141-51. Epub 2009 Apr 8.

University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672454PMC
http://dx.doi.org/10.2147/vhrm.s4664DOI Listing
June 2009

New treatments in type 2 diabetes: a focus on the incretin-based therapies.

Clin Endocrinol (Oxf) 2009 Mar 2;70(3):343-53. Epub 2008 Sep 2.

University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2008.03396.xDOI Listing
March 2009

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

Adv Ther 2009 Mar 27;26(3):249-62. Epub 2009 Mar 27.

Undergraduate Center, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-009-0014-9
Publisher Site
http://dx.doi.org/10.1007/s12325-009-0014-9DOI Listing
March 2009

Drug evaluation: vildagliptin-metformin single-tablet combination.

Adv Ther 2009 Feb 19;26(2):138-54. Epub 2009 Mar 19.

NIHR Research Training Fellow, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-009-0010-0DOI Listing
February 2009

Exenatide: incretin therapy for patients with Type 2 diabetes mellitus.

Expert Rev Endocrinol Metab 2008 Nov;3(6):671-690

c Division of Medical Sciences, University of Birmingham and Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17446651.3.6.671DOI Listing
November 2008

Treatment intensification in patients with type 2 diabetes.

Diabetes Obes Metab 2008 Jun;10 Suppl 1:iii

Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust and University of Birmingham, Birmingham Heartlands Hospital, Undergraduate Centre, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1463-1326.2008.00889.xDOI Listing
June 2008

Securing recruitment and obtaining informed consent in minority ethnic groups in the UK.

BMC Health Serv Res 2008 Mar 30;8:68. Epub 2008 Mar 30.

Faculty of Health & Social Care, The Open University, Milton Keynes, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6963-8-68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311303PMC
March 2008

The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.

Diab Vasc Dis Res 2008 Mar;5(1):9-14

Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.3132/dvdr.2008.002
Publisher Site
http://dx.doi.org/10.3132/dvdr.2008.002DOI Listing
March 2008

Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status.

Menopause 2007 Nov-Dec;14(6):1031-8

Women's Unit, Solihull Hospital and University of Birmingham, Heart of England NHS Foundation Trust, Lode Lane Solihull, West Midlands, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/gme.0b013e31803c56b6DOI Listing
February 2008

The future of inhaled insulin and incretinmimetics in the management of diabetes.

Prim Care Diabetes 2008 Feb 4;2(1):59-61. Epub 2008 Mar 4.

Department of Diabetes/Endocrinology, University of Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S175199180800002
Publisher Site
http://dx.doi.org/10.1016/j.pcd.2008.01.001DOI Listing
February 2008

Physical activity and risk of diabetes.

Lancet 2008 Jan;371(9606):5-7

Faculty of Health & Social Care, Open University, Milton Keynes, Buckinghamshire, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(08)60044-6DOI Listing
January 2008

Value of glycaemic control in diabetes.

Lancet 2008 Jan;371(9607):116

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(08)60101-4DOI Listing
January 2008

Latent autoimmune diabetes in adults in a South Asian population of the U.K.

Diabetes Care 2007 Dec 18;30(12):3088-90. Epub 2007 Sep 18.

Department of Medicine, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/cgi/doi/10.2337/dc07-0896
Publisher Site
http://dx.doi.org/10.2337/dc07-0896DOI Listing
December 2007

Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes.

Curr Med Res Opin 2007 Dec;23(12):2921-7

University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079907X233313DOI Listing
December 2007

Selection and education of patients for inhaled insulin.

Curr Diab Rep 2007 Oct;7(5):363-8

Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham, UK.

View Article

Download full-text PDF

Source
October 2007

Inhaled human insulin (Exubera): clinical profile and patient considerations.

Vasc Health Risk Manag 2007 ;3(1):83-91

University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994047PMC
August 2007

Glucose tolerance testing for all?

Int J Clin Pract 2007 Apr;61(4):541-3

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1742-1241.2007.01307.x
Publisher Site
http://dx.doi.org/10.1111/j.1742-1241.2007.01307.xDOI Listing
April 2007

Insulin glargine in the treatment of type 1 and type 2 diabetes.

Vasc Health Risk Manag 2006 ;2(1):59-67

Birmingham Heartlands Hospital, Undergraduate Centre, Birmingham, West Midlands, England, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993975PMC
http://dx.doi.org/10.2147/vhrm.2006.2.1.59DOI Listing
March 2007

Inhaled insulin (Exubera): Combining efficacy and convenience.

Diab Vasc Dis Res 2006 Dec;3(3):179-85

Department of Medicine-Undergraduate Centre, Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.3132/dvdr.2006.027
Publisher Site
http://dx.doi.org/10.3132/dvdr.2006.027DOI Listing
December 2006

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

Diabetes Care 2006 Jun;29(6):1282-7

University of Birmingham and Heart of England NHS Foundation Trust (Teaching), Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc05-1879DOI Listing
June 2006